Details for 2014840833

Up to date per 01.04.2026

Actions

Title / Product Name

ORAL ANZUWENDENDE ARZNEIFORMULIERUNG MIT OMARIGLIPTIN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2014840833

EP Publication Number

3038465

E-Number

1435620

Language

PCT Number

US14052451

Publication Date

06.07.2016 A

06.10.2021 B1

Registration Date

06.10.2021

AT Publication Date

15.10.2021

Application Date

25.08.2014

Registration Number

Priorities

30.08.2013

201361871951 P

IPC

A61K 9/20 20060101AFI20210315BHEP

Maximum Duration of Protection

25.08.2034

Owner

Merck Sharp & Dohme Corp.126 East Lincoln Avenue Rahway, NJ 07065-0907US

Merck Sharp & Dohme LimitedHertford Road Hoddesdon, Hertfordshire EN11 9BUGB

Representative

No representatives present

Inventor

COOPER, Vincent, Brett106 Roundmoor Drive Cheshunt Hertfordshire EN8 9HHGB

BRADLEY, Kathryn, Alanna42 Whitecroft St. Albans Hertfordshire AL1 1UUGB

PYGALL, Samuel, RobertHertford Road Hoddesdon Hertfordshire EN11 9BUGB

GUPTA, Rajan603 Ivyshaw Road Cary, NC 27519US

STANFORD, Madison, Paige556 Morris Avenue Summit, NJ 07901US

XIE, Lin556 Morris Avenue Summit, NJ 07901US